4
Changes in Ownership
Atrium Therapeutics, Inc. Filed Acc 0001193125-26-397951
Director gave up 126,418 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyce Sarah Director | 2026-09-18 | Shares withheld for taxes | −126,418 | $8.95 | $1,131,441 | 138,668 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…